Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

☰

Vertex Consolidating R&D Ops in 3 Locations, Shutters Site in Canada

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/top-news-815x384-vertex.jpg" NAME"Vertex Consolidating R&D Ops in 3 Locations, Shutters Site in Canada" ALT"Vertex Consolidating R&D Ops in 3 Locations, Shutters Site in Canada"March 29, 2017By Mark Terry, BioSpace.com Breaking…

Continue ReadingVertex Consolidating R&D Ops in 3 Locations, Shutters Site in Canada

What a Day! Genentech Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/genentech.jpg" NAME"What a Day! Genentech Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis" ALT"What a Day! Genentech Lands FDA Approval for First Drug to Treat Severe…

Continue ReadingWhat a Day! Genentech Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis

And It Begins…Looks to Cut $1.2 Billion of NIH R&D Spending This Year

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-donald-trump5.jpg" NAME"And It Begins...President Trump Looks to Cut $1.2 Billion of NIH R&D Spending This Year" ALT"And It Begins...President Trump Looks to Cut $1.2 Billion of NIH R&D Spending…

Continue ReadingAnd It Begins…Looks to Cut $1.2 Billion of NIH R&D Spending This Year

Bay Area's Depomed Craters as New CEO, Directors are Named in Deal With Activist Investor

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks-down.jpg" NAME"Trump's FDA Head Nominee to Recuse Himself From Decisions Involving 20 CompaniesBay Area's Depomed Craters as New CEO, Directors are Named in Deal with Activist Investor" ALT"Bay Area's…

Continue ReadingBay Area's Depomed Craters as New CEO, Directors are Named in Deal With Activist Investor